These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33766036)

  • 1. Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study.
    Yubero-Serrano EM; Alcalá-Diaz JF; Gutierrez-Mariscal FM; Arenas-de Larriva AP; Peña-Orihuela PJ; Blanco-Rojo R; Martinez-Botas J; Torres-Peña JD; Perez-Martinez P; Ordovas JM; Delgado-Lista J; Gómez-Coronado D; Lopez-Miranda J
    Cardiovasc Diabetol; 2021 Mar; 20(1):72. PubMed ID: 33766036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary heart disease risk equivalence in diabetes and arterial diseases characterized by endothelial function and endothelial progenitor cell.
    Liao YF; Feng Y; Chen LL; Zeng TS; Yu F; Hu LJ
    J Diabetes Complications; 2014; 28(2):214-8. PubMed ID: 24332936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial.
    Blanco-Rojo R; Perez-Martinez P; Lopez-Moreno J; Martinez-Botas J; Delgado-Lista J; van-Ommen B; Yubero-Serrano E; Camargo A; Ordovas JM; Perez-Jimenez F; Gomez-Coronado D; Lopez-Miranda J
    Sci Rep; 2017 Oct; 7(1):12499. PubMed ID: 28970513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol Efflux Capacity Associates with the Ankle-Brachial Index but Not All-Cause Mortality in Patients with Peripheral Artery Disease.
    Clemens RK; Hunjadi M; Ritsch A; Rohrer L; Meier TO; Amann-Vesti B; von Eckardstein A; Annema W
    Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol mass efflux capacity and risk of peripheral artery disease: The Multi-Ethnic Study of Atherosclerosis.
    Garg PK; Jorgensen NW; McClelland RL; Allison M; Stein JH; Yvan-Chavret L; Tall AR; Shea S
    Atherosclerosis; 2020 Mar; 297():81-86. PubMed ID: 32097805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Anacetrapib on Cholesterol Efflux Capacity: A Substudy of the DEFINE Trial.
    Metzinger MP; Saldanha S; Gulati J; Patel KV; El-Ghazali A; Deodhar S; Joshi PH; Ayers C; Rohatgi A
    J Am Heart Assoc; 2020 Dec; 9(24):e018136. PubMed ID: 33263263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D deficiency is associated with risk of developing peripheral arterial disease in type 2 diabetic patients.
    Yuan J; Jia P; Hua L; Xin Z; Yang JK
    BMC Cardiovasc Disord; 2019 Jun; 19(1):145. PubMed ID: 31208330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ankle-brachial index for assessing the prevalence of peripheral artery disease and cardiovascular risk in patients with type 2 diabetes mellitus.
    Sartore G; Caprino R; Ragazzi E; Bianchi L; Lapolla A; Piarulli F
    Nutr Metab Cardiovasc Dis; 2023 Mar; 33(3):560-567. PubMed ID: 36646602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL/apo B ratio predict coronary heart disease in Type 2 diabetes independent of ASCVD risk score: A case-cohort study.
    Rabizadeh S; Rajab A; Mechanick JI; Moosaie F; Rahimi Y; Nakhjavani M; Esteghamati A
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1477-1485. PubMed ID: 33810957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study.
    Bertrand C; Saulnier PJ; Potier L; Croyal M; Blanchard V; Gand E; Ragot S; Schneider F; Bocock O; Baillet-Blanco L; Velho G; Marre M; Roussel R; Rigalleau V; Hadjadj S; Mohammedi K;
    Diabetologia; 2021 Mar; 64(3):668-680. PubMed ID: 33409569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
    van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
    Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere length as biomarker of nutritional therapy for prevention of type 2 diabetes mellitus development in patients with coronary heart disease: CORDIOPREV randomised controlled trial.
    Ojeda-Rodriguez A; Rangel-Zuñiga OA; Arenas-de Larriva AP; Gutierrez-Mariscal FM; Torres-Peña JD; Romero-Cabrera JL; Podadera-Herreros A; García-Fernandez H; Porras-Pérez E; Luque RM; Kales SN; Perez-Martinez P; Delgado-Lista J; Yubero-Serrano EM; Lopez-Miranda J
    Cardiovasc Diabetol; 2024 Mar; 23(1):98. PubMed ID: 38493287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors.
    Agarwal AK; Singh M; Arya V; Garg U; Singh VP; Jain V
    J Assoc Physicians India; 2012 Jul; 60():28-32. PubMed ID: 23405538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.
    González-Clemente JM; Piniés JA; Calle-Pascual A; Saavedra A; Sánchez C; Bellido D; Martín-Folgueras T; Moraga I; Recasens A; Girbés J; Sánchez-Zamorano MA; Mauricio D;
    Diabet Med; 2008 Apr; 25(4):427-34. PubMed ID: 18341592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial Dysfunction and Advanced Glycation End Products in Patients with Newly Diagnosed Versus Established Diabetes: From the CORDIOPREV Study.
    de la Cruz-Ares S; Cardelo MP; Gutiérrez-Mariscal FM; Torres-Peña JD; García-Rios A; Katsiki N; Malagón MM; López-Miranda J; Pérez-Martínez P; Yubero-Serrano EM
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral arterial disease and its correlates in patients with type 2 diabetes mellitus in a teaching hospital in northern Nigeria: a cross-sectional study.
    Agboghoroma OF; Akemokwe FM; Puepet FH
    BMC Cardiovasc Disord; 2020 Feb; 20(1):102. PubMed ID: 32111165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease.
    Pan L; Lu G; Chen Z
    Coron Artery Dis; 2014 Aug; 25(5):433-8. PubMed ID: 24608795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of plasma fetuin-a levels with peripheral arterial disease and lower extremity arterial calcification in subjects with type 2 diabetes mellitus.
    Eleftheriadou I; Grigoropoulou P; Kokkinos A; Mourouzis I; Perrea D; Katsilambros N; Sfikakis PP; Tentolouris N
    J Diabetes Complications; 2017 Mar; 31(3):599-604. PubMed ID: 27899247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of lipoprotein(a) and apolipoprotein(a) phenotypes with peripheral artery disease.
    Tmoyan NA; Ezhov MV; Afanasieva OI; Klesareva EA; Razova OA; Kukharchuk VV; Pokrovsky SN
    Ter Arkh; 2018 Sep; 90(9):31-36. PubMed ID: 30701732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral arterial disease progression and ankle brachial index: a cohort study with newly diagnosed patients with type 2 diabetes.
    Felício JS; de Melo FTC; Vieira GM; de Aquino VT; de Souza Parente F; da Silva WM; Said NM; da Silva ER; de Souza ACCB; de Oliveira MCNI; de Lemos GN; de Souza ÍJA; de Alcântara AL; de Moraes LV; Abrahão Neto JF; de Queiroz NNM; Mourão NAL; Piani PPF; Oliveira Dos Reis MS; Felício KM
    BMC Cardiovasc Disord; 2022 Jun; 22(1):294. PubMed ID: 35761179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.